Review: could Nasonex cause Haemorrhagic Transformation Stroke?


Summary

Haemorrhagic transformation stroke is found among people who take Nasonex, especially for people who are female, 20-29 old , have been taking the drug for 2 - 5 years, also take medication Loratadine, and have Contraception . We study 13,329 people who have side effects while taking Nasonex from FDA and social media. Among them, 8 have Haemorrhagic transformation stroke. Find out below who they are, when they have Haemorrhagic transformation stroke and more.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Nasonex

Nasonex has active ingredients of mometasone furoate monohydrate. It is often used in hypersensitivity. (latest outcomes from Nasonex 18,053 users)

Haemorrhagic Transformation Stroke

Haemorrhagic transformation stroke (haemorrhages develop inside areas of ischemia) (latest reports from 428 Haemorrhagic transformation stroke patients).

On Aug, 25, 2016

13,329 people reported to have side effects when taking Nasonex.
Among them, 8 people (0.06%) have Haemorrhagic Transformation Stroke


Number of reports submitted per year:

Could Nasonex cause Haemorrhagic transformation stroke?

Time on Nasonex when people have Haemorrhagic Transformation Stroke *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 100 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Haemorrhagic Transformation Stroke when taking Nasonex *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Haemorrhagic Transformation Stroke when taking Nasonex *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 87.5 %
  • 30-39: 0.0 %
  • 40-49: 12.5 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Top conditions involved for these people *:

  • Contraception (6 people, 75.00%)
  • Dizziness (3 people, 37.50%)
  • Multiple Sclerosis (1 person, 12.50%)
  • Multiple Myeloma (1 person, 12.50%)
  • Cerebral Thrombosis (1 person, 12.50%)

Top co-used drugs for these people *:

  • Loratadine (8 people, 100.00%)
  • Rhinocort (7 people, 87.50%)
  • Patanol (7 people, 87.50%)
  • Nsaid's (7 people, 87.50%)
  • Acetaminophen (7 people, 87.50%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Haemorrhagic transformation stroke when taking Nasonex?

Browse all side effects of Nasonex

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Haemorrhagic transformation stroke

Haemorrhagic transformation stroke

Could your condition cause Haemorrhagic transformation stroke

Haemorrhagic transformation stroke

Related studies

You may be interested in these reviews

More reviews for: Nasonex, Haemorrhagic transformation stroke


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.